Logo title:  The Nathan S. Kline Institute For Psychiatric Research, N.Y. State Office of Mental Health  
Site Index Links Directions Search:  
   
 Peptide Research Laboratory

Koon-Sea Hui, Ph.D., Director

Our laboratory studies the neurochemistry underlying mental health and disease by examining brain-specific proteins and neuropeptide metabolism. Brain-specific proteins are pivotal biomarkers and powerful tools for studying of neural mechanisms and neuropathology. Their functions have been identified in neurotransmitter metabolism, cell-to-cell recognition, differentiation, signal transduction, glycolysis, gene expression, receptors, ion channels, and the cytoskeleton. Focusing on neuropeptide metabolism, we were the first to find a brain-specific protein, BP-170, with increased expression in post-mortem schizophrenic brain.

The role of peptidases in neuropeptide inactivation has become evident; they offer a rational target for therapeutic intervention through modulation of their activity. Enkephalins are endogenous opioid peptides that modulate pain, anxiety, aggression, and immune response. The bioactive opioid peptides -- enkephalins, b-endorphin, dynorphin, and orphanin -- are inactivated by proteolytic metabolism. We aim to find the key enzyme that terminates enkephalin actions. Recent findings indicate a neuronal location associated with restricted substrate selectivity of a peptidase constitute a functional 'neuropeptidase'. Using a sensitive and specific aminopeptidase analyzer, we found a novel neuron-specific aminopeptidase exclusive to brain. The unique localization of the enzyme and its developmental expression profile imply a role in nociception, neuronal growth, and differentiation.

We are concurrently exploring the possibility of developing a new line of analgesics that are devoid of opiate's unwanted side-effects, including tolerance and physical dependence, in studying brain peptidases and their endogenous and synthetic inhibitors. We identified and characterized the first endogenous inhibitor (anti-enkephalinase) for enkephalin metabolism. We plan to find a potent inhibitor in the brain and to synthesize compounds that are innovative analgesics.

For further information, contact Dr. Hui at


Nathan S. Kline Institute for Psychiatric Research
140 Old Orangeburg Road
Orangeburg, NY 10962
Phone: 845-398-5500
Fax: 845-398-5510